Oxycodone Hydrochloride
Product Images NDC 73780-004

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxycodone Hydrochloride (NDC 73780-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohemo Life Sciences Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxycodone 15 mg (Oxycodone 15 mg Ag)

Oxycodone 15 mg (Oxycodone 15 mg Ag)
Oxycodone Hydrochloride 15 mg tablets packaging label showing 100 tablets. The label states the active ingredient strength, storage instructions, and child-resistant container requirements. It includes identification details for the tablets and manufacturer information for Ohemo Life Sciences Inc.*
FDA Label Image

Oxycodone 30 mg (Oxycodone 30 mg Ag)

Oxycodone 30 mg (Oxycodone 30 mg Ag)
Oxycodone Hydrochloride 30 mg tablets packaging label showing 100 tablets per container. The label features the active ingredient oxycodone hydrochloride USP 30 mg, storage instructions, and instructions for dispensing with a child-resistant closure. It identifies the manufacturer as Ohemo Life Sciences Inc., Juncos, PR. The label includes tablet identification markings and a note for dispensers to provide a medication guide to patients.*
FDA Label Image

Oxycodone 5 mg (Oxycodone 5 mg Ag)

Oxycodone 5 mg (Oxycodone 5 mg Ag)
Oxycodone Hydrochloride 5 mg tablets label showing a bottle containing 100 tablets. The label includes the NDC 73780-001-10 and states the active ingredient strength, storage instructions, and dispensing requirements. The labeler is Ohemo Life Sciences Inc., Juncos, PR. The tablets are identified by markings IDT/0 5 and the label notes a medication guide must be provided upon dispensing.*
FDA Label Image

Structural Formula (Rox02 0005 02)

Structural Formula (Rox02 0005 02)
Chemical structure depicting the molecular formula C18H21NO4·HCl, representing the active ingredient Oxycodone Hydrochloride. The diagram shows the arrangement of atoms including carbon, hydrogen, oxygen, nitrogen, and the hydrochloride component, accompanied by the molecular weight of 351.82.*
FDA Label Image

Oxycodone Pk Profile (Roxy01 New)

Oxycodone Pk Profile (Roxy01 New)
A line graph depicting the concentration (ng/mL) of Oxycodone hydrochloride in the blood over time (hours) after dosing with tablets of three strengths: 5 mg, 15 mg, and 30 mg. The graph shows concentration peaking earlier and higher with increasing dosage, then gradually declining over 24 hours. The different doses are represented by distinct markers for each line.*
FDA Label Image

Oxycodone Linking Graph (Roxy02 New)

Oxycodone Linking Graph (Roxy02 New)
A line graph depicting Drug Liking Visual Analog Scale (VAS) measurements in millimeters over a 24-hour period. The graph compares four groups: Crushed Intranasal Oxycodone immediate-release tablets, Crushed Intranasal Oxycodone hydrochloride tablets, Intact Oral Oxycodone hydrochloride tablets, and Placebo, showing differences in drug liking over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.